360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Sanofi SA

Image source: Freebase

Type: Company

Name: Sanofi SA

Nationality: France

Fact Sheet: Fact Sheet for Sanofi-Aventis SA

First reported 5 hours ago - Updated 1 hour ago - 2 reports

Asthma Antibody Drug New Hope for 25 Million Americans?

.Saved under Headlines, Health, Janet Grace Ortigas, U.S., WorldSanofi and Regeneron Pharmaceuticals is developing Dupilumab, an antibody drug to give hope to patients whose condition is not controlled by their existing medicines. Is this new drug hope ... [Published The Guardian Express - 1 hour ago]

Entities: Asthma, Antibody, New Hope Corporation Ltd, Drugs

First reported 2 hours ago - Updated 2 hours ago - 1 reports

Regeneron and Sanofi: An Unstoppable Biotech Duo?

This morning, positive results from a phase 2a study testing an experimental asthma drug developed by biotech Regeneron (NASDAQ: REGN ) and big pharma company Sanofi (NYSE: SNY ) were published in the New England Journal of Medicine. In the following ... [Published Motley Fool Discussion Boards - 2 hours ago]

Entities: Regeneron, Sanofi SA, Biotechnology

First reported 3 hours ago - Updated 3 hours ago - 1 reports

Sanofi SA

Skadden: French Autorité de la Concurrence Fines Sanofi €40.6 Million for Denigrating Competing Generics

French Autorité de la Concurrence Fines Sanofi €40.6 Million for Denigrating Competing GenericsSkaddenMay 21, 20133 pages ... [Published MyCorporateResource.com - 3 hours ago]

Entities: Sanofi SA

First reported 5 hours ago - Updated 5 hours ago - 1 reports

French Autorité de la Concurrence Fines Sanofi €40.6 Million for Denigrating Competing Generics

" "May 21, 2013 | Skadden, Arps, Slate, Meagher & Flom LLP | Simon Baxter, Frederic Depoortere, Ingrid Vandenborre, James S. VenitOn May 14, 2013, the French Autorité de la Concurrence (Autorité) issued a decision imposing a fine of €40.6 million on ... [Published Skadden - 5 hours ago]

Entities: Sanofi SA, Plavix, Clopidogrel, Aspirin

First reported 6 hours ago - Updated 6 hours ago - 1 reports

Sanofi SA Rating Reiterated by Oddo & Cie (SAN)

Oddo & Cie reiterated their buy rating on shares of Sanofi SA (EPA: SAN) in a research note issued to investors on Friday, ARN reports. The firm currently has a €91.00 ($118.18) target price on the stock.Shares of Sanofi SA ( EPA: SAN ) traded up 0.98% ... [Published Mideast Time - 6 hours ago]

Entities: Sanofi SA, Stocks, Helvea, Bryan Garnier & Co

First reported May 20 2013 - Updated 7 hours ago - 9 reports

Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Asthma Drug Seen as Potential Game Changer

/PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and (NASDAQ: REGN) today announced that the New England Journal of Medicine published online the positive Phase 2a study results of dupilumab (SAR231893/REGN668) in patients with moderate-to-severe ... [Published BioSpace - 7 hours ago]

Entities: Regeneron Pharmaceuticals Inc, Sanofi SA, Asthma

First reported 10 hours ago - Updated 10 hours ago - 1 reports

Standard & Poor's

Sanofi (SNY) $54.37 up $0.98...

Today 10:53 AM ET (S&P Capital IQ)PrintSTRATEGY: Look at the September 55 covered call. For each 100 shares of Sanofi (SNY) stock you buy, sell one September 55 covered call option for a $52.12 ($54.37 - $2.25) debit or better. That's potentially a 5.5% ... [Published TD Ameritrade - 10 hours ago]

Entities: Sanofi SA, Standard & Poor's, Anticoagulant, Blood Cell

First reported 12 hours ago - Updated 10 hours ago - 3 reports

ZEALAND PHARMA AKTIESELSKABET: Zealand to present at upcoming global healthcare investor conferences in the US

Copenhagen, 2013-05-21 15:00 CEST (GLOBE NEWSWIRE) --Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) ("Zealand"),a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, informs it will present at the following ... [Published 4 Traders - 10 hours ago]

Entities: Zealand Pharma A/S, Health Care, David H Solomon, Lixisenatide

First reported 11 hours ago - Updated 11 hours ago - 1 reports

Sanofi announces management changes

Sanofi has announced that Peter Guenter, currently senior vice president, Europe, Sanofi, will be appointed executive vice president, global commercial operations and Pascale Witz, currently president and CEO of medical diagnostics at GE Healthcare, will ... [Published Individual.com - 11 hours ago]

Entities: Sanofi SA, Pascale Witz, Appointed, GE Healthcare

First reported 12 hours ago - Updated 12 hours ago - 2 reports

Door Security at Genzyme, a Sanofi Company, Enhanced with Door...

Top Biotech Company Using Tailgate Detection Solution in Many Buildings Orders More Units to Strengthen Security in Multi-Use Facility. , provider of premium, innovative entrance control and outdoor security solutions, today announced that Genzyme, a ... [Published PRWeb - 12 hours ago]

Entities: Genzyme Corp, Sanofi SA, Security

First reported 19 hours ago - Updated 19 hours ago - 1 reports

Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation

With operations in more than 100 countries and more than 110,000 staff, global healthcare company Sanofi (NYSE: SNY EURONEXT: SAN) needed a way to streamline processes and transform its technology infrastructure into an efficient global network. To do ... [Published Stockwatch - 19 hours ago]

Entities: Axway Software SA, Sanofi SA, Infrastructure, NYSE Euronext Inc

First reported May 20 2013 - Updated May 20 2013 - 2 reports

Sanofi reconsiders closure plans in Toulouse after government pressure

Report says research site can remain open with minimum job lossesSanofi has decided not to close its research facility in Toulouse after pressure from the French government, saving a proportion of the jobs under threat at least in the short term.The pharma ... [Published PMLive - May 20 2013]

Entities: Sanofi SA, Toulouse, Research & Development

Quotes

...And as pediatric infectious diseases specialist Dr. H Cody Meissner told Reuters Health, "It's very hard to recommend a vaccine that is known to be associated with more side effects than another vaccine that's safer, even though the first vaccine gives better protection."

Old whooping cough vax linked with better protection [Published FierceVaccines - 1 hour ago]

"Establishing Valeant's international headquarters in the Montreal region provides tangible benefits for Quebec and its economy. Thanks to our actions, we are consolidating high-level jobs in an ultraspecialized sector and are keeping the expertise and know-how in Quebec" added Mr. Dessureault

Valeant opens international headquarters in Laval [Published Stockwatch - 2 hours ago]

...Corporation, Dermik, a division of Sanofi, and, more recently, California-based Obagi Medical Products, which specialize in dermatological care. "Establishing Valeant's international headquarters in the Montreal Valeant's acquisition of Dermik in 2011 for approximately $425 million"

A first in Quebec: Valeant officially inaugurates its international headquarters in Laval [Published Digital Journal - 2 hours ago]

"Until novel strategies are found, the study by Leuppi, et al, provides convincing evidence that less is more for steroid use in chronic obstructive pulmonary disease and that a 5-day regimen rather than the 10-day to 14-day course recommended by most national and international guidelines ... this is welcome news for patients for COPD who experience multiple exacerbations annually and are exposed to repeated course of systemic corticosteroids" they wrote

5-Day Steroid Tx Works in COPD (CME/CE) [Published MedPage Today - 4 hours ago]

More Content

sort by: Date \| Relevance
Asthma Antibody Drug New Hope for 25 Million Am... [Published The Guardian Express - 1 hour ago]
Cell Therapeutics, Inc. Presents at UBS Global ... [Published Seeking Alpha - 1 hour ago]
Old whooping cough vax linked with better prote... [Published FierceVaccines - 1 hour ago]
Valeant opens international headquarters in Laval [Published Stockwatch - 2 hours ago]
Regeneron Eyes Potential Blockbuster With Asthm... [Published Xconomy - 2 hours ago]
A first in Quebec: Valeant officially inaugurat... [Published Digital Journal - 2 hours ago]
A first in Quebec: Valeant officially inaugurat... [Published Canada NewsWire - 2 hours ago]
Regeneron and Sanofi: An Unstoppable Biotech Duo? [Published Motley Fool Discussion Boards - 3 hours ago]
Novartis Ramping Up Alzheimer’s Pursuit as Riva... [Published Bloomberg - 3 hours ago]
Skadden: French Autorité de la Concurrence Fi... [Published MyCorporateResource.com - 3 hours ago]
5-Day Steroid Tx Works in COPD (CME/CE) [Published MedPage Today - 4 hours ago]
Regulus to Present at Deutsche Bank 38th Annual... [Published Bio-Medicine - 4 hours ago]
UPDATE 1-Regeneron, Sanofi asthma drug seen as ... [Published Reuters UK - 5 hours ago]
Monoclonal Antibody Dupilumab Safe And Effectiv... [Published Scientific Blogging - Medicine - 5 hours ago]
Regulus to Present at Deutsche Bank 38th Annual... [Published Street Insider - 5 hours ago]
Regulus to Present at Deutsche Bank 38th Annual... [Published FinanzNachrichten.de - 5 hours ago]
REGULUS THERAPEUTICS INC: Regulus to Present at... [Published 4 Traders - 5 hours ago]
French Autorité de la Concurrence Fines Sanofi ... [Published Skadden - 5 hours ago]
Head hunter Russell Reynolds adds health care h... [Published Birmingham Star - 6 hours ago]
Global Pharmaceutical & Biotechnology Outlook 2... [Published TransWorldNews - 6 hours ago]
Sanofi SA Rating Reiterated by Oddo & Cie (SAN) [Published Mideast Time - 6 hours ago]
Bedminster solar project foes gain environmenta... [Published Bernardsville News - 7 hours ago]
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi ... [Published BioSpace - 7 hours ago]
Head hunter Russell Reynolds adds health care h... [Published New York Business Journal - 7 hours ago]
Jerome "The Bus" Bettis Promotes Auvi-Q With an... [Published Pharma Marketing Blog - 8 hours ago]
The Logic Of Biologics - Is Regeneron The Next ... [Published Forbes.com - 8 hours ago]
Transgene and Sofimac Partners Invest in Antibo... [Published PE Hub News - 8 hours ago]
ADR REPORT-ADRs little changed as Fed clues sought [Published Reuters - 8 hours ago]
Nicolas Cartier appointed Corporate Vice Presid... [Published BioMérieux SA - 8 hours ago]
Travel Vaccines Market to 2019 [Published companiesandmarkets.com - 9 hours ago]

Blogs

sort by: Date \| Relevance
Monoclonal Antibody Dupilumab Safe And Effectiv... [Published Scientific Blogging - Medicine - 5 hours ago] A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to researchers. The randomized, double-blind, placebo-controlled trial tested the efficacy ...
Jerome "The Bus" Bettis Promotes Auvi-Q With an... [Published Pharma Marketing Blog - 8 hours ago] Celebrity spokespeople seem to be all the rage in pharma marketing circles these days. I wonder, however, how closely the FDA is watching celebrity endorsements such as former NFLer Jerome Jerome “The Bus” Bettis's promotion of Sanofi's talking epinephrine ...
Sanofi (SNY) Could Break Through $54.59 Resista... [Published MarketIntelligenceCenter.com - 13 hours ago] Sanofi-Aventis (NYSE: SNY) closed Monday's trading session at $53.84. In the past year, the stock has hit a 52-week low of $33.03 and 52-week high of $55.77. Sanofi (SNY) stock has been showing support around $53.47 and resistance in the $54.59 range. ...
How Much Do Drug Companies Spend on R&D, Anyway? [Published In the Pipeline - May 20 2013] How much does Big Pharma spend on R&D, compared to what it takes in? This topic came up during a discussion here last week, when a recent article at The Atlantic referred to these expenditures as "only" 16 cents on the dollar, and I wanted to return ...
1 Great Dividend You Can Buy Right Now [Published EquityJungle - v0.1 - May 19 2013] Filed under: Investing Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable. In others, the dividend is so low, it's not even worth the paper ...

Audio/Video

sort by: Date \| Relevance
Jean-Jacques Bienaimé, Chief Executive Officer,... [Published BIO Channel - YouTube - Feb 26 2013]
Big Pharma Competes to Treat Very Rare Diseases [Published WSJ.com Video - Business - Jan 30 2013]
Don't Wait to Buy Wells Fargo, Sanofi [Published TheStreet.com - YouTube - Dec 24 2012]
Sanofi-Aventis to Pay $109M to Resolve False Cl... [Published FOX Business - Video - Dec 19 2012]

Press Releases

sort by: Date \| Relevance
Sanofi and Regeneron Announce Publication of Po... [Published PR Newswire: Health - 13 hours ago]
Sanofi si affida ad Axway per creare un'infrast... [Published Business Wire Technology News - 19 hours ago]
Sanofi fait confiance à Axway pour pérenniser s... [Published Business Wire Technology News - 19 hours ago]
Sanofi konsolidiert IT-Infrastruktur und verrin... [Published Business Wire Technology News - 19 hours ago]
Sanofi Relies on Axway to Future-Proof their In... [Published Business Wire Technology News - 19 hours ago]